Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues:        
License and other revenues $ 1,000 $ 1,346
Expenses:        
Royalties 350 350
Research and development 6,658 8,533 17,203 16,868
General and administrative 3,460 5,182 7,684 11,444
Impairment of licensed technology 1,355
Impairment of right-of-use lease asset 1,561
Impairment of construction-in-progress (1,460) 1,792
Total expenses 9,008 13,715 29,945 28,312
Loss from operations (8,008) (13,715) (28,599) (28,312)
Interest and other income 30 8 31 23
Interest expense (317) (1,500) (518) (2,920)
Net loss (8,295) (15,207) (29,086) (31,209)
Deemed dividends related to Series A and Series B Convertible Redeemable Preferred Stock (3,782) (3,782)
Net loss attributable to Common Shareholders $ (12,077) $ (15,207) $ (32,868) $ (31,209)
Basic and diluted loss per common share $ (2.08) $ (3.93) $ (5.67) $ (8.18)
Weighted average number of common shares outstanding – basic and diluted 5,806,473 3,864,791 5,800,822 3,817,380
Other comprehensive income (loss):        
Change in unrealized gains related to available-for-sale debt securities $ (4) $ (4) $ (7) $ 9
Comprehensive losses $ (12,081) $ (15,211) $ (32,875) $ (31,200)